Pharmaceutical Packaging Companies

The pharmaceutical packaging market is projected to reach USD 364.11 billion by 2030 from USD 174.85 billion in 2025, at a CAGR of 15.8% during the forecast period. The pharmaceutical packaging industry has continued to grow, driven by the demand for safe, convenient, and sustainable packaging options for injectables, oral solids, biologics, and specialty drugs. Increasing regulatory demands for product safety, adherence, and product traceability are driving the increased adoption of new packaging technologies, including prefillable syringes, child-resistant closures, tamper-evident formats, and smart packaging. In addition, the growing emphasis on eco-friendly and recyclable materials supports long-term industry expansion, with pharmaceutical companies seeking packaging partners that align with global sustainability initiatives. Emerging trends such as unit-dose packaging, digital-enabled tracking systems, and innovations in barrier properties to improve drug stability continue to shape the market’s direction.

Pharmaceutical Packaging Companies

The major pharmaceutical packaging players that account for a significant portion of the market include Amcor plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), AptarGroup, Inc. (US), and BD (US). These companies promote competition through product innovation, growth initiatives, partnerships, and mergers, and emphasize customized packaging solutions to meet the varied pharmaceutical needs. Though the top five companies have only a modest share of the global market, their large scale and high levels of R&D mean that they are a major player in the industry. Additionally, many regional and niche players continue to add to the fragmentation of the market and increased competition, creating options for pharmaceutical manufacturers across the globe.

To know about the assumptions considered for the study download the pdf brochure

Amcor plc is a leading packaging company for food, beverage, pharmaceutical, medical, home & personal care, and other products. It is primarily involved in the manufacturing and marketing of flexible packaging, rigid containers, and specialty cartons and closures by using raw materials such as polymers, aluminum foils, and fibers. Amcor plc operates a substantial global network of manufacturing and support facilities across its two main segments: Flexibles and Rigid Packaging. The Flexibles segment comprises 160 significant facilities spanning 36 countries, of which 111 are directly owned by the company and 49 are leased from external parties. The typical initial lease terms for these facilities range from two to 36 years, often including one or more renewal options. In comparison, the Rigid Packaging segment includes 52 significant facilities across 11 countries, with a smaller proportion owned directly by the company—12 facilities—while the remaining 40 are leased. Lease terms for the Rigid Packaging facilities generally range from two to 20 years and frequently provide renewal options. This distribution highlights the Flexibles segment’s larger global footprint and greater ownership of facilities, while the Rigid Packaging segment relies more heavily on leased properties. Amcor plc has a wide range of healthcare packaging for oral, dermal, medical devices, hospital packaging, ophthalmic & vision care, pulmonary, intravenous fluid, and injectables. It performs its operations through subsidiaries in the EMEA (Europe, the Middle East, and Africa), the Americas, and Asia Pacific. The company operates through 212 production sites in more than 40 countries.

Gerresheimer AG is a recognized leader in the global marketplace for pharmaceutical packaging, drug delivery devices, and integrated healthcare solutions, serving pharmaceutical and biotechnology customers throughout the world. Gerresheimer develops and supplies primary packaging solutions made from glass and plastic for medicines, diagnostics, and healthcare applications. Gerresheimer has three operating segments: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies, with pharmaceutical packaging mainly within the Plastics & Devices and Primary Packaging Glass segments. Gerresheimer has a global manufacturing network consisting of 36 plants located in 15 countries, including Germany, Belgium, France, Spain, Denmark, Switzerland, Poland, the Czech Republic, North Macedonia, Mexico, Brazil, the US, India, China, and Singapore, to ensure the company has local proximity to major pharma hubs and customers. Gerresheimer’s wide product portfolio, from vials, ampoules, and syringes to complex drug delivery systems and customized solutions, combines innovation and strong regulatory compliance with a global supply and manufacturing capacity to meet the healthcare industry’s demanding quality and regulatory standards.

Schott AG manufactures high-tech materials for specialty glasses. The company operates as a subsidiary of Carl-Zeiss-Stiftung (Germany). It operates through precision materials, optical industries, home appliances, and trade & others. The packaging business is conducted through its precision materials business division. Schott AG serves numerous industries, including healthcare, home appliances & living, consumer electronics, semiconductors & datacom, optics, industry & energy, automotive, and astronomy & aerospace. Schott established its subsidiary, Schott Pharma, to advance its growth strategy for its pharma business, particularly in drug containment and delivery solutions. Schott Pharma’s product line includes drug containment options to drug delivery systems, such as pharmaceutical syringes, cartridges, vials, and ampoules, with over 13 billion drug containers produced yearly. Schott AG offers glass tubing and primary packaging, including syringes, vials, ampoules, and cartridges for the pharmaceutical industry. Schott has manufacturing sites and sales offices in 34 countries and 600 production sites in 13 countries. The company has a total of 17,400 employees working globally.

AptarGroup, Inc. is a leading manufacturer of sealing, packaging, and innovative dispensing solutions. It operates through beauty & home, pharma, and food & beverage business segments. The pharmaceutical packaging business is a part of its pharma business segment and has four divisions: prescription drug, consumer health care, injectables, and active packaging. AptarGroup, Inc. is among the top companies in drug delivery devices for respiratory medicines and allergic rhinitis. The company’s product portfolio includes drug delivery systems such as nasal spray systems, active packaging, metered-dose inhaler valves, elastomeric primary packaging, dispensing closures, pumps, aerosol valves, and related solutions that support both the protection of diagnostics/medicines and patient-friendly drug delivery. The company operates in 20 countries, working across the food and beverage, pharmaceutical, beauty, personal care, and home care industries. The company’s pharmaceutical packaging manufacturing facilities are in Argentina, Brazil, Colombia, Italy, Thailand, the Czech Republic, Spain, Switzerland, Mexico, China, France, Germany, India, and the US.

BD (Becton, Dickinson, and Company) is among top global medical technology company focused on the research, development, manufacture, and sale of a variety of medical supplies, devices, laboratory instruments, and diagnostic products.. BD’s products are used in healthcare institutions, by physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. BD functions across three primary business segments: BD Medical, BD Life Sciences, and BD Interventional, with the objective of providing innovative solutions to improve patient outcomes and healthcare delivery efficiencies.. The company conducts its pharmaceutical packaging through the BD medical business segment, which has four divisions: medical delivery solutions, medication management solutions, diabetes care, and pharmaceutical systems. It offers products such as needles, syringes, and intravenous catheters. The company has over 33,000 patents and operates in more than 190 countries globally and has production facilities in the US, Brazil, Canada, China, France, Germany, Hungary, India, Ireland, Japan, Mexico, the Netherlands, Pakistan, Singapore, Spain, Sweden, and the UK.

Market Ranking

The pharmaceutical packaging market is fragmented, with the leading five companies, Amcor plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), AptarGroup, Inc. (US), and BD (US) accounting for around 15–20% of the global market share. These companies sustain their market leadership by offering full ranges of primary, secondary, and tertiary pharmaceutical packaging while innovating by creating sustainable materials and drug delivery formats focused on patients. Their strategic investments, compliance with government regulations, and expansion into new markets will remain their areas of concentration in order to solidify their market position and address growing demand for safe and effective drug packaging solutions.

Related Reports:

Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Global Forecast to 2030